AIM
Aigen Investment Management Portfolio holdings
AUM
$730M
1-Year Return
13.63%
This Quarter Return
+8.17%
1 Year Return
+13.63%
3 Year Return
+38.05%
5 Year Return
+65.25%
10 Year Return
–
AUM
$459M
AUM Growth
-$102M
(-18%)
Cap. Flow
-$114M
Cap. Flow
% of AUM
-24.73%
Top 10 Holdings %
Top 10 Hldgs %
8.69%
Holding
1,090
New
334
Increased
127
Reduced
178
Closed
451
Top Buys
| 1 |
Eli Lilly
LLY
|
$6.63M |
| 2 |
American Water Works
AWK
|
$4.08M |
| 3 |
Mondelez International
MDLZ
|
$3.68M |
| 4 |
Intercontinental Exchange
ICE
|
$3.5M |
| 5 |
Linde
LIN
|
$3.44M |
Top Sells
| 1 |
Exxon Mobil
XOM
|
$5.79M |
| 2 |
NVIDIA
NVDA
|
$5.69M |
| 3 |
APA Corp
APA
|
$4.8M |
| 4 |
Whirlpool
WHR
|
$4.62M |
| 5 |
Visa
V
|
$4.41M |
Sector Composition
| 1 | Consumer Discretionary | 20.11% |
| 2 | Technology | 15.42% |
| 3 | Industrials | 12.02% |
| 4 | Healthcare | 11.47% |
| 5 | Financials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Dine Brands
DIN
$364M
| $461K | 0.1% |
9,915
+4,411
| +80% | +$205K |
|
302
Mohawk Industries
MHK
$8.65B
| $459K | 0.1% |
3,507
-1,871
| -35% | -$245K |
|
303
Griffon
GFF
$3.79B
| $457K | 0.1% |
+6,229
| New | +$457K |
|
304
Halliburton
HAL
$18.8B
| $454K | 0.1% |
11,522
-11,316
| -50% | -$446K |
|
305
CRISPR Therapeutics
CRSP
$4.99B
| $454K | 0.1% |
+6,656
| New | +$454K |
|
306
RxSight
RXST
$364M
| $453K | 0.1% |
8,782
-479
| -5% | -$24.7K |
|
307
Howmet Aerospace
HWM
$71.8B
| $452K | 0.1% |
+6,600
| New | +$452K |
|
308
FTAI Aviation
FTAI
$15.8B
| $451K | 0.1% |
+6,699
| New | +$451K |
|
309
Viper Energy
VNOM
$6.29B
| $447K | 0.1% |
+11,620
| New | +$447K |
|
310
Globe Life
GL
$11.3B
| $444K | 0.1% |
+3,815
| New | +$444K |
|
311
Winnebago Industries
WGO
$1.03B
| $442K | 0.1% |
5,972
+752
| +14% | +$55.6K |
|
312
Ameris Bancorp
ABCB
$5.08B
| $442K | 0.1% |
+9,131
| New | +$442K |
|
313
American States Water
AWR
$2.88B
| $441K | 0.1% |
+6,110
| New | +$441K |
|
314
News Corp Class B
NWS
$18.8B
| $440K | 0.1% |
+16,250
| New | +$440K |
|
|
BPMC
315
DELISTED
Blueprint Medicines
BPMC
| $439K | 0.1% |
+4,624
| New | +$439K |
|
316
JD.com
JD
$44.6B
| $437K | 0.1% |
15,962
-55,034
| -78% | -$1.51M |
|
|
UCB
317
United Community Banks, Inc.
UCB
$4.04B
| $436K | 0.1% |
16,578
-20,152
| -55% | -$530K |
|
318
Caesars Entertainment
CZR
$5.48B
| $435K | 0.09% |
+9,941
| New | +$435K |
|
319
Nutanix
NTNX
$18.7B
| $434K | 0.09% |
7,036
+2,813
| +67% | +$174K |
|
320
Dana Inc
DAN
$2.7B
| $433K | 0.09% |
+34,106
| New | +$433K |
|
321
Edwards Lifesciences
EW
$47.5B
| $433K | 0.09% |
+4,532
| New | +$433K |
|
322
Sensient Technologies
SXT
$4.79B
| $433K | 0.09% |
6,258
-2,410
| -28% | -$167K |
|
323
Open Text
OTEX
$8.45B
| $431K | 0.09% |
11,115
+1,753
| +19% | +$68K |
|
324
Snap
SNAP
$12.4B
| $431K | 0.09% |
37,514
+14,104
| +60% | +$162K |
|
325
Toast
TOST
$24B
| $427K | 0.09% |
17,129
-49,908
| -74% | -$1.24M |
|